New drug tested for men with spreading prostate cancer
Disease control
Terminated
This early-stage trial tested a new drug called LAE001 for men with advanced prostate cancer that had spread and stopped responding to standard hormone therapy. The study aimed to find a safe dose and see if the drug could help control the cancer. All participants continued their…
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC